Editor's Note: At OBR we have created an editorial board of renown thought leaders in different cancer disease areas. The role of our editorial board is to provide valuable insights through editorial commentary accompanying our daily news. We call it virtual access. By providing our insights into the daily news, you will have access into how these thought leading oncologists interpret the oncology news and events we carry in OBR daily. We hope that our editorial boards's insights will bring great value to the oncology community.
Professor and Chair, Department of Breast Medical Oncology The University of Texas MD Anderson Cancer Center
These findings are an example of the power of genomic sequencing and bioinformatic analysis - with a…
Distinguished Professor of Medicine, Rutgers Robert Wood Johnson Medical School Rutgers-CINJ Associate Director, Clinical Research Director Clinical Oncology Research, RWJ-B Health System
Great work by Mike Overman and colleagues showing prolonged benefit to Nivo (3 mg,kg) and Ipi (1 mg,…
Director WVU Cancer Institute Director of Cancer Signature Program Laurence S. and Jean J. DeLynn Chair of Oncology
This is a very interesting study that opens the door to prospective investigation of a randomized tr…
Executive Director Community Oncology Alliance
A total of 31 oncologists and only from academic centers, medical centers, and the VA. No community …
National Health Policy Expert
One tweet struck me in this story about the update on Amazon, JP Morgan and Berkshire and it is:
 
Medical Director, Thoracic Oncology Program, Swedish Cancer Institute, Seattle, WA; CEO, Global Resource for Advancing Cancer Education (GRACE)
This is a disappointing result, particularly considering how low the bar is to beat third line stand…
President, W-Squared Group
CMS has set the reimbursement for their near normal outpatient rate, thus CMS is treating the CAR-T …
Managing Director and Senior Biotechnology Analyst
I am excited to be joining the editorial board on OBR; I have been a fan of the publication since it…
Chief Medical Officer and Founder, N-of-One
No comments to show!
Professor and Director, Division of Hematology Oncology Department of Medicine,Cedars-Sinai Medical Center Associate Director for Academic Program Development Samuel Oschin Comprehensive Cancer Institute Professor of Medicine and Urology, Emeritus David Geffen School of Medicine at UCLA
This long awaited trial performed by the National Cancer Institute demonstrates the benefits of low …
FACP FACPE FASCO President, Minnesota Oncology
There is no quicker way to "burn out" physicians than to put them "at risk" for expenses that they c…
CEO Tennessee Oncology
There are certainly some perverse incentives in medicine but there is a significant literature that …
Vice President Integrated Community Oncology Network Former Community Representative ASCO Board of Directors
Clearly the risk for a drug payment bundle could be prohibitive. The variation from practice to prac…
Florida Cancer Specialists President and Managing Partner
At Florida Cancer Specialists we have been using DigniCap for several months at 3 of our site and it…
Ronald H. Bloom Chair in Cancer Therapeutics
Professor and Chair, Department of Radiation Oncology
Interim Director, Samuel Oschin Comprehensive Cancer Institute
Cedars-Sinai Medical Center
Interesting experience using focal radiation techniques (with injected radiation) to treat HCC. Ther…
